Advertisement

The Latest

While millions of Americans set New Year’s resolutions, Altamonte Springs, Fla.-based AdventHealth’s president and CEO, David Banks, is taking a different approach for 2026.  “This may sound countercultural, but this new year, I’m not thinking about resolutions,” Mr. Banks said…

Indiana Attorney General Todd Rokita has filed a lawsuit against Eli Lilly, alleging the company contributed to inflated insulin prices over the past decade. The state is seeking injunctive relief, damages and penalties for what it describes as deceptive market…

Kankakee, Ill.-based Riverside Healthcare has partnered with radiology technology vendor CIVIE to modernize imaging services across six sites in five counties. Riverside implemented CIVIE’s RadPod teleradiology platform and RadFlow picture archiving and communication system to reduce image turnaround times and…

Lander, Wyo.-based SageWest Health Care has named Amanda Vick, BSN, as CEO of its two hospitals, effective Jan. 5. Ms. Vick returns to SageWest after serving in several leadership roles at Scottsbluff, Neb.-based Regional West Health Services, according to a…

UAB Health System in Birmingham, Ala., acquired Southview Medical Group, also in Birmingham, Jan. 1. Southview Medical Group is a multi-specialty practice that specializes in diagnosis, prevention and treatment. It comprises 30 providers and provides care to more than 51,000…

Methodist Fremont Health in Nebraska has named Michele Williams, MD, to serve as chief medical officer. Dr. Williams is an emergency medicine physician and has worked in several leadership roles at the hospital over the past five years, including as…

W.L. Gore & Associates has received FDA approval for the Gore Viabahn Fortegra Venous Stent — the first device indicated to treat deep venous disease in the inferior vena cava, as well as the iliac and iliofemoral veins. Formerly known…

Large language models frequently misrepresent verbal risk terms used in medicine, potentially amplifying patient misunderstandings and diverging from established clinical definitions, according to a study spearheaded by researchers from Vanderbilt Health in Nashville, Tenn. The findings, published Dec. 17 in…

Amneal Pharmaceuticals received FDA approval for two denosumab biosimilars referencing Prolia and Xgeva. The approval, announced Dec. 22, covers Boncresa (denosumab-mobz) and Oziltus (denosumab-mobz), both used to treat conditions related to bone loss and cancer. The drugs are administered by…

Advertisement